Emerging evidence indicates that longitudinal declines in COVES correlates with poor outcomes in patients with aneurysmal subarachnoid hemorrhage (aSAH), but the clinical factors associated with a low ...

Background This study explores racial and socioeconomic disparities in aneurysmal subarachnoid hemorrhage (aSAH) care, highlighting the impact on treatment and outcomes. The study aims to shed light ...

Hyponatremia commonly occurs in patients with aneurysmal subarachnoid hemorrhage. Two mechanisms have been proposed as causes: syndrome of inappropriate anti-diuretic hormone and cerebral salt ...

Hyponatremia is a serum sodium concentration level of less than 135 mEq/L (< 135 mmole/L, SI) for at least 1 day (Kurokawa et al., 1996). A value of less than 120 mEq/L is considered a critical ...

OBJECTIVES To measure the sensitivity and specificity of five MRI sequences to subarachnoid haemorrhage. METHODS Forty one patients presenting with histories suspicious of subarachnoid haemorrhage ...

Satralizumab is under clinical development by F. Hoffmann-La Roche and currently in Phase III for Demyelinating Diseases.

We are still learning how to identify and interpret these artifacts. Aneurysm wall enhancement for identification of ruptured aneurysms Accurate non-invasive identification of the source of hemorrhage ...

Shelly Gill collapsed without warning in the driver's seat. Her devastated family was told she would die or suffer severe ...